Our study was designed to evaluate the kinetics and expression of CD28 and CD152 on unstimulated and anti–CD3+rIL-2-stimulated CD4+ and CD8+ T lymphocytes from B-CLL patients. This evidence concerns the gene CTLA4 and B-cell chronic lymphocytic leukemia.